首页 | 官方网站   微博 | 高级检索  
     

海洋细菌中活性化合物的筛选策略
引用本文:陈菲菲,林灵,王以光,周红霞,陶佩珍,赫卫清,王勇.海洋细菌中活性化合物的筛选策略[J].中国抗生素杂志,2011,36(5).
作者姓名:陈菲菲  林灵  王以光  周红霞  陶佩珍  赫卫清  王勇
作者单位:1. 中国医药集团四川抗菌素工业研究所,成都,610052;中国医学科学院/北京协和医学院,医药生物技术研究所,卫生部抗生素生物技术重点实验室,北京,100050
2. 中国医学科学院/北京协和医学院,医药生物技术研究所,卫生部抗生素生物技术重点实验室,北京,100050;东北农业大学,哈尔滨,150030
3. 中国医学科学院/北京协和医学院,医药生物技术研究所,卫生部抗生素生物技术重点实验室,北京,100050
4. 中国医药集团四川抗菌素工业研究所,成都,610052;中国科学院上海生命科学研究院植物生理生态研究所合成生物学重点实验室,上海,200032
摘    要:目的 从700多株海洋沉积物分离得到的细菌中筛选安莎类抗生素和6-脱氧己糖(6DOH)糖基化修饰的次级代谢产物产生菌.方法 以3-氨基-5-羟基苯甲酸(AHBA)合酶基因和dTDP-葡萄糖-4,6-脱水酶基因为靶标,分别进行安莎类抗生素和6DOH糖基化修饰的次级代谢产物产生菌的分子筛选.对AHBA合酶及dTDP-葡萄糖-4,6-脱水酶基因阳性的菌株发酵液及提取物进行抗菌、抗肿瘤、抗病毒活性分析.采用利福霉素抗性及氢氧化钠显色初步鉴定安莎类化合物;采用α-萘酚硫酸显色初步鉴定6DOH糖基化修饰的化合物.利用16S rRNA序列对部分阳性菌株进行系统发育分析.结果 共获得39株AHBA合酶基因阳性和10株dTDP-葡萄糖-4,6-脱水酶基因阳性菌株.阳性菌株中,78%具有不同程度的生物活性.化学初步鉴定结果表明:49%的AHBA合酶基因阳性菌株产生安莎类化合物:50%的dTDP-葡萄糖-4,6-脱水酶基因阳性菌株产生6DOH糖基化修饰的化合物.系统发育分析表明,大多数阳性菌株属于放线菌中的链霉菌属.结论 基因探针筛选可作为一种合理、有效的方法从海洋细菌中发现活性代谢产物.

关 键 词:海洋细菌  基因探针筛选  安莎类抗生素  6-脱氧己糖(6DOH)糖基化修饰的化合物  生物活性

A strategy for discovery of bioactive metabolites from marine bacteria
Chen Fei-fei,Lin Ling,Wang Yi-guang,Zhou Hong-xia,Tao Pei-zhen,He Wei-qing,Wang Yong.A strategy for discovery of bioactive metabolites from marine bacteria[J].Chinese Journal of Antibiotics,2011,36(5).
Authors:Chen Fei-fei  Lin Ling  Wang Yi-guang  Zhou Hong-xia  Tao Pei-zhen  He Wei-qing  Wang Yong
Affiliation:Chen Fei-fei1,2,Lin Ling2,3,Wang Yi-guang2,Zhou Hong-xia2,Tao Pei-zhen2,He Wei-qing2 and Wang Yong1,4(1 Sichuan Industrial Institute of Antibiotics,Chengdu 610052,2 Key Lab of Antibiotics Biotechnology,Ministry of Health,Institute of Medicinal Biotechnoloy,CAMS&PUMC,Beijing 100050,3 Northeast Agricultural University,Harbin 150030,4 Key Laboratory of Synthetic Biology,Institute of Plant Physiology and Ecology,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai,2000321)
Abstract:Objective To screen ansamycin and 6-deoxyhexoses (6DOH) glycosylated secondary metabolites producers from more than 700 marine-sediment bacteria. Methods A gene-probe screening strategy was established targeting the 3-amino-5-hydroxybenzoic acid (AHBA) synthase and dTDP-glucose-4,6-dehydratase genes for discovering ansamycins and 6DOH glycosylated secondary metabolites, respectively. Bioactivities of the AHBA synthase and dTDP-glucose-4,6-dehydratase gene-positive strains were evaluated, including anti-bacterial, anti- tumoral and anti-viral activities. Rifamycin resistance profiles and color reactions with sodium hydroxyl or α naphthol were performed as preliminary identification of potential ansamycin or 6DOH glycosylated secondary metabolite producers. Taxonomic and phylogenetic analysis of some positive strains was conducted using partial 16S rRNA sequences. Results In total, 39 AHBA synthase gene-positive and 10 dTDP-glucose-4,6-dehydratase gene-positive strains were obtained. Of these positive strains, 78% showed varying degrees of biological activities. Preliminary chemical identification of metabolites showed that 49% of AHBA synthase gene-positive strains probably produced ansamycins while 50% of dTDP-glucose-4,6-dehydratase gene-positive strains might produce 6DOH glycosylated compounds. Taxonomic and phylogenetic analysis indicated that most of these positive strains belonged to Streptomyces. Conclusion The results suggested that gene-probe screening was a rational and effective strategy for discovering bioactive metabolites from marine bacteria.
Keywords:Marine bacteria  Gene-probe screening  Ansamycins  6-Deoxyhexoses (6DOH) glycosylated compounds  Bioactivities
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号